Type 2 diabetes mellitus (T2DM) is associated with impaired leptomeningeal collateral compensation and poor stroke outcome. Neutrophils tethering and rolling on endothelium after stroke can also independently reduce flow velocity. However, the chronology and topological changes in collateral circulation in T2DM is not yet defined. Here, we describe the spatial and temporal blood flow dynamics and vessel diameter changes in pial arteries and veins and leukocyte-endothelial adhesion following middle cerebral artery (MCA) stroke using two-photon microscopy in awake control and T2DM mice. Relative to control mice, T2DM mice already exhibited smaller pial vessels with reduced flow velocity prior to stroke. Following stroke, T2DM mice displayed persistently reduced blood flow in pial arteries and veins, resulting in a poor recovery of downstream penetrating arterial flow and a sustained deficit in microvascular flow. There was also persistent increase of leukocyte adhesion to the endothelium of veins, coincided with elevated neutrophils infiltration into brain parenchyma in T2DM mice compared to control mice after stroke. Our data suggest that T2DM-induced increase in inflammation and chronic remodeling of leptomeningeal vessels may contribute to the observed hemodynamics deficiency after stroke and subsequent poor stroke outcome.
SatoYFalcone-JuengertJTominagaT, et al.
Remodeling of the neurovascular unit following cerebral ischemia and hemorrhage. Cells2022;
11: 2823.
2.
BangOYGoyalMLiebeskindDS.Collateral circulation in ischemic stroke: Assessment tools and therapeutic strategies. Stroke2015;
46: 3302–3309.
3.
MosenzonOChengAYRabinsteinAA, et al.
Diabetes and stroke: what are the connections?J Stroke2023;
25: 26–38.
4.
GoldsteinLBAdamsRBeckerK, et al.
Primary prevention of ischemic stroke: a statement for healthcare professionals from the stroke council of the American Heart Association. Circulation2001;
103: 163–182.
5.
LauLHLewJBorschmannK, et al.
Prevalence of diabetes and its effects on stroke outcomes: a meta-analysis and literature review. J Diabetes Investig2019;
10: 780–792.
6.
CuiYLiangXGuH, et al.
Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction. Brain Imaging Behav2017;
11: 1248–1257.
7.
LinLYangJChenC, INSPIRE study groupet al.
Association of collateral status and ischemic core growth in patients with acute ischemic stroke. Neurology2021;
96: e161–e170.
8.
YaghiSDehkharghaniSRazE, et al.
The effect of hyperglycemia on infarct growth after reperfusion: an analysis of the DEFUSE 3 trial. J Stroke Cerebrovasc Dis2021;
30: 105380.
9.
TurhanHYasarASErbayAR, et al.
Impaired coronary collateral vessel development in patients with metabolic syndrome. Coron Artery Dis2005;
16: 281–285.
10.
KalmarPJTarkanyiGKaradiZN, et al.
The impact of diabetes mellitus and admission hyperglycemia on clinical outcomes after recanalization therapies for acute ischemic stroke: STAY ALIVE national prospective registry. Life (Basel)2022;
12: 632.
11.
KanokeAAkamatsuYNishijimaY, et al.
The impact of native leptomeningeal collateralization on rapid blood flow recruitment following ischemic stroke. J Cereb Blood Flow Metab2020;
40: 2165–2178.
12.
BinderNFEl AmkiMGluckC, et al.
Leptomeningeal collaterals regulate reperfusion in ischemic stroke and rescue the brain from futile recanalization. Neuron2024;
112: 1456–1472.e6. e1456.
13.
AkamatsuYNishijimaYLeeCC, et al.
Impaired leptomeningeal collateral flow contributes to the poor outcome following experimental stroke in the type 2 diabetic mice. J Neurosci2015;
35: 3851–3864.
14.
NishijimaYAkamatsuYYangSY, et al.
Impaired collateral flow compensation during chronic cerebral hypoperfusion in the type 2 diabetic mice. Stroke2016;
47: 3014–3021.
15.
JianZLiuRZhuX, et al.
The involvement and therapy target of immune cells after ischemic stroke. Front Immunol2019;
10: 2167.
16.
SilvermanMNSternbergEM.Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci2012;
1261: 55–63.
TangCWangCZhangY, et al.
Recognition, intervention, and monitoring of neutrophils in acute ischemic stroke. Nano Lett2019;
19: 4470–4477.
19.
BettermannKSinhaKKumariR, et al.
The peripheral immune response in hyperglycemic stroke. Clin Neurol Neurosurg2020;
195: 106061.
20.
KumariRBettermannKWillingL, et al.
The role of neutrophils in mediating stroke injury in the diabetic db/db mouse brain following hypoxia-ischemia. Neurochem Int2020;
139: 104790.
21.
ChapmanGBCokeletGR.Model studies of leukocyte-endothelium-blood interactions. II. Hemodynamic impact of leukocytes adherent to the wall of post-capillary vessels. Biorheology1997;
34: 37–56.
22.
ChapmanGBCokeletGR.Flow resistance and drag forces due to multiple adherent leukocytes in postcapillary vessels. Biophys J1998;
74: 3292–3301.
23.
TavernerKMuradYYasunagaAB, et al.
The effect of type-2 diabetes conditions on neutrophil rolling adhesion. BMC Res Notes2022;
15: 355.
24.
Diaz-MoralesNRovira-LlopisSBanulsC, et al.
Does metformin protect diabetic patients from oxidative stress and Leukocyte-Endothelium interactions?Antioxid Redox Signal2017;
27: 1439–1445.
25.
PezhmanLTahraniAChimenM.Dysregulation of leukocyte trafficking in type 2 diabetes: mechanisms and potential therapeutic avenues. Front Cell Dev Biol2021;
9: 624184.
26.
KilkennyCBrowneWCuthillIC, et al.
Animal research: reporting in vivo experiments–the ARRIVE guidelines. J Cereb Blood Flow Metab2011;
31: 991–993.
27.
Percie du SertNHurstVAhluwaliaA, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, et al.
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol2020;
18: e3000410.
28.
Cruz HernándezJCBrackoOKersbergenCJ, et al.
Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer’s disease mouse models. Nat Neurosci2019;
22: 413–420.
29.
DrewPJBlinderPCauwenberghsG, et al.
Rapid determination of particle velocity from space-time images using the radon transform. J Comput Neurosci2010;
29: 5–11.
30.
ChhatbarPYKaraP.Improved blood velocity measurements with a hybrid image filtering and iterative radon transform algorithm. Front Neurosci2013;
7: 106.
31.
ShihAYDriscollJDDrewPJ, et al.
Two-photon microscopy as a tool to study blood flow and neurovascular coupling in the rodent brain. J Cereb Blood Flow Metab2012;
32: 1277–1309.
32.
KanokeANishijimaYLjungbergM, et al.
The effect of type 2 diabetes on CD36 expression and the uptake of oxLDL: diabetes affects CD36 and oxLDL uptake. Exp Neurol2020;
334: 113461.
33.
SetoATaylorSTrudeauD, et al.
Induction of ischemic stroke in awake freely moving mice reveals that isoflurane anesthesia can mask the benefits of a neuroprotection therapy. Front Neuroenergetics2014;
6: 1.
34.
SlupeAMKirschJR.Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection. J Cereb Blood Flow Metab2018;
38: 2192–2208.
35.
MenonBKSmithEECouttsSB, et al.
Leptomeningeal collaterals are associated with modifiable metabolic risk factors. Ann Neurol2013;
74: 241–248.
36.
ZhouXZhangJFengG, et al.
Nitric Oxide-Releasing biomaterials for biomedical applications. Curr Med Chem2016;
23: 2579–2601.
37.
TerpolilliNAKimSWThalSC, et al.
Inhalation of nitric oxide prevents ischemic brain damage in experimental stroke by selective dilatation of collateral arterioles. Circ Res2012;
110: 727–738.
38.
KiddGADobruckiLWBrovkovychV, et al.
Nitric oxide deficiency contributes to large cerebral infarct size. Hypertension2000;
35: 1111–1118.
39.
De VrieseASVerbeurenTJVan de VoordeJ, et al.
Endothelial dysfunction in diabetes. Br J Pharmacol2000;
130: 963–974.
40.
LiQAtochinDKashiwagiS, et al.
Deficient eNOS phosphorylation is a mechanism for diabetic vascular dysfunction contributing to increased stroke size. Stroke2013;
44: 3183–3188.
41.
VerkleijCJBruijnREMeestersEW, et al.
The hemostatic system in patients with type 2 diabetes with and without cardiovascular disease. Clin Appl Thromb Hemost2011;
17: E57–63.
42.
VaidyaARWolskaNVaraD, et al.
Diabetes and thrombosis: a Central role for vascular oxidative stress. Antioxidants (Basel)2021;
10: 706.
43.
LiuJWangYAkamatsuY, et al.
Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials. Prog Neurobiol2014;
115: 138–156.
44.
NishijimaYAkamatsuYWeinsteinPR, et al.
Collaterals: implications in cerebral ischemic diseases and therapeutic interventions. Brain Res2015;
1623: 18–29.
45.
SatoYOmodakaSWongS, et al.
Type 2 diabetes dampens neuroprotection against ischemic injury by lipopolysaccharide-induced preconditioning. Stroke2023;
54: AWMP112.
46.
ConnollyESJrWinfreeCJPrestigiacomoCJ, et al.
Exacerbation of cerebral injury in mice that express the P-selectin gene: identification of P-selectin blockade as a new target for the treatment of stroke. Circ Res1997;
81: 304–310.
47.
TinocoROteroDCTakahashiAA, et al.
PSGL-1: a new player in the immune checkpoint landscape. Trends Immunol2017;
38: 323–335.
48.
KitagawaKMatsumotoMMabuchiT, et al.
Deficiency of intercellular adhesion molecule 1 attenuates microcirculatory disturbance and infarction size in focal cerebral ischemia. J Cereb Blood Flow Metab1998;
18: 1336–1345.
49.
Use of anti-ICAM-1 therapy in ischemic stroke: results of the enlimomab acute stroke trial. Neurology2001;
57: 1428–1434.
50.
SorianoSGCoxonAWangYF, et al.
Mice deficient in mac-1 (CD11b/CD18) are less susceptible to cerebral ischemia/reperfusion injury. Stroke1999;
30: 134–139.
51.
BeckerKJ.Anti-leukocyte antibodies: leukArrest (Hu23F2G) and enlimomab (R6.5) in acute stroke. Curr Med Res Opin2002;
18 Suppl 2: s18–22.
52.
KramsMLeesKRHackeW, et al.
Acute stroke therapy by inhibition of neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke2003;
34: 2543–2548.
53.
KozukaKKohriyamaTNomuraE, et al.
Endothelial markers and adhesion molecules in acute ischemic stroke–sequential change and differences in stroke subtype. Atherosclerosis2002;
161: 161–168.
54.
WangQZhaoWBaiS.Association between plasma soluble P-selectin elements and progressive ischemic stroke. Exp Ther Med2013;
5: 1427–1433.
SatoYWongSRabillerG, et al.
The suppression of leukocyte rolling via blocking P-selectin after stroke is not sustained in mice with type 2 diabetes. Stroke2022;
53ATP242-ATP242.
57.
Schmid-SchoenbeinGWFungYCZweifachBW.Vascular endothelium-leukocyte interaction; sticking shear force in venules. Circ Res1975;
36: 173–184.
58.
SimonSIGoldsmithHL.Leukocyte adhesion dynamics in shear flow. Ann Biomed Eng2002;
30: 315–332.
59.
MunnLLMelderRJJainRK.Role of erythrocytes in leukocyte-endothelial interactions: mathematical model and experimental validation. Biophys J1996;
71: 466–478.
60.
MunnLLDupinMM.Blood cell interactions and segregation in flow. Ann Biomed Eng2008;
36: 534–544.
61.
KrollMHHellumsJDMcIntireLV, et al.
Platelets and shear stress. Blood1996;
88: 1525–1541.
62.
El AmkiMGluckCBinderN, et al.
Neutrophils obstructing brain capillaries are a major cause of no-reflow in ischemic stroke. Cell Rep2020;
33: 108260.
63.
RolfesLRiek-BurchardtMPawlitzkiM, et al.
Neutrophil granulocytes promote flow stagnation due to dynamic capillary stalls following experimental stroke. Brain Behav Immun2021;
93: 322–330.
64.
Rovira-LlopisSBañulsCApostolovaN, et al.
Is glycemic control modulating endoplasmic reticulum stress in leukocytes of type 2 diabetic patients?Antioxid Redox Signal2014;
21: 1759–1765.
65.
Alba-LoureiroTCMunhozCDMartinsJO, et al.
Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res2007;
40: 1037–1044.
66.
JicklingGCLiuDAnderBP, et al.
Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab2015;
35: 888–901.
67.
DarboussetRThomasGMMezouarS, et al.
Tissue factor-positive neutrophils bind to injured endothelial wall and initiate thrombus formation. Blood2012;
120: 2133–2143.
68.
von BrühlMLStarkKSteinhartA, et al.
Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med2012;
209: 819–835.
69.
JinRYuSSongZ, et al.
Soluble CD40 ligand stimulates CD40-dependent activation of the β2 integrin mac-1 and protein kinase C zeda (PKCζ) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst. PLoS One2013;
8: e64631.
70.
HalleviHHazan-HalevyIParanE.Modification of neutrophil adhesion to human endothelial cell line in acute ischemic stroke by dipyridamole and candesartan. Eur J Neurol2007;
14: 1002–1007.
71.
VickersJD.Binding of polymerizing fibrin to integrin alpha(IIb)beta(3) on chymotrypsin-treated rabbit platelets decreases phosphatidylinositol 4,5-bisphosphate and increases cytoskeletal actin. Platelets1999;
10: 228–237.
72.
FuchsTABrillADuerschmiedD, et al.
Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A2010;
107: 15880–15885.
73.
MassbergSGrahlLvon BruehlML, et al.
Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med2010;
16: 887–896.
74.
HackamDGSpenceJD.Antiplatelet therapy in ischemic stroke and transient ischemic attack. Stroke2019;
50: 773–778.
75.
EmerichDFDeanRLBartusRT.The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?Exp Neurol2002;
173: 168–181.
76.
RabillerGIpZZarrabianS, et al.
Type-2 diabetes alters hippocampal neural oscillations and disrupts synchrony between the hippocampus and cortex. Aging Dis2023; 15: 2255–2270.
77.
AdigaUBanawalikarNMayurS, et al.
Association of insulin resistance and leptin receptor gene polymorphism in type 2 diabetes mellitus. J Chin Med Assoc2021;
84: 383–388.
78.
LydenPDBosettiFDinizMA, SPAN Investigatorset al.
The stroke preclinical assessment network: rationale, design, feasibility, and stage 1 results. Stroke2022;
53: 1802–1812.
79.
LydenPDDinizMABosettiF, et al.
A multi-laboratory preclinical trial in rodents to assess treatment candidates for acute ischemic stroke. Sci Transl Med2023;
15: eadg8656.
80.
BurkeSJBatdorfHMBurkDH, et al.
db/db mice exhibit features of human type 2 diabetes that are not present in weight-matched C57BL/6J mice fed a Western diet. J Diabetes Res2017;
2017: 8503754.
81.
MoraisAImaiTJinX, et al.
Biological and procedural predictors of outcome in the stroke preclinical assessment network (SPAN) trial. Circ Res2024;
135: 575–592.
82.
KottaisamyCPDRajDSPrasanth KumarV, et al.
Experimental animal models for diabetes and its related complications-a review. Lab Anim Res2021;
37: 23.
83.
PandeySChmelirTChottova DvorakovaM.Animal models in diabetic research-history, presence, and future perspectives. Biomedicines2023;
11: 2852.
84.
YagihashiS.Contribution of animal models to diabetes research: its history, significance, and translation to humans. J Diabetes Investig2023;
14: 1015–1037.
85.
HaydenMR.Type 2 diabetes mellitus increases the risk of late-onset Alzheimer’s disease: ultrastructural remodeling of the neurovascular unit and diabetic gliopathy. Brain Sci2019;
9: 262.
86.
FrikerLLScheiblichHHochheiserIV, et al.
β-amyloid clustering around ASC fibrils boosts its toxicity in microglia. Cell Rep2020;
30: 3743–3754.e6. e3746.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
